Skip to product information
1 of 1

Carlo Maria Masieri

Medical Malpractice Legislation: Reforms in Civil Law Systems

Medical Malpractice Legislation: Reforms in Civil Law Systems

Low Stock: Only 2 copies remaining
Regular price £45.07 GBP
Regular price £48.99 GBP Sale price £45.07 GBP
8% OFF Sold out
Tax included. Shipping calculated at checkout.

YOU SAVE £3.92

  • Condition: Brand new
  • UK Delivery times: Usually arrives within 2 - 3 working days
  • UK Shipping: Fee starts at £2.39. Subject to product weight & dimension
Trustpilot 4.5 stars rating  Excellent
We're rated excellent on Trustpilot.
  • More about Medical Malpractice Legislation: Reforms in Civil Law Systems

This book analyzes the legal tools adopted by France, Germany, and Italy to regulate medical malpractice, focusing on the medical malpractice crisis and its relationship with the insurance market. It reconstructs the legal frameworks, insurance and litigation contexts, and examines the statutes passed, distinguishing between reforms that consolidate case law and those that introduce innovative solutions. The third chapter reviews and analyzes the current data related to medical malpractice litigation and insurance after the reforms, highlighting some aspects that still belong to the judiciary.

Format: Hardback
Length: 114 pages
Publication date: 08 May 2024
Publisher: Taylor & Francis Ltd


This book aims to analyze the legal tools that the legislatures of France, Germany, and Italy adopted in order to regulate medical malpractice. In the mid-1970s, a reform movement started in the United States, where there was considerable concern about the ongoing medical malpractice crises. Since the beginning of the current century, France, Germany, and Italy have passed statutes that aim to reform medical liability rules. Thus, it is first interesting to assess whether any medical malpractice crises have been identified in these systems and, second, how these have been faced through the passing of new statutes on the Continent. Accordingly, the first chapter explores the idea of medical malpractice crisis and its relationship with the insurance market, also considering the reflections of American scholars. It then reconstructs the French, German, and Italian legal frameworks, as well as their insurance and litigation contexts, reviewing and commenting on the quantitative evidence that was collected before the reforms. The second chapter briefly summarizes the debate on Medical Malpractice reforms in France, Germany, and Italy. It then analyzes the statutes that have been passed, distinguishing between reforms that consolidate case law and reforms that introduce innovative solutions, sometimes repealing court-developed doctrines. In particular, the chapter examines in a comparative perspective the different options adopted in these Civil Law countries with regard to the rules on liability, burden of proof, statute of limitations, and damages. Moreover, the chapter examines the reforms of insurance, procedural, and evidence law, to the extent they affect medical malpractice cases. The third chapter reviews and analyzes the current available data related to medical malpractice litigation.



Introduction:

In the mid-1970s, a reform movement started in the United States, where there was considerable concern about the ongoing medical malpractice crises. Medical malpractice refers to the legal responsibility of healthcare professionals for their negligence or wrongdoing in providing medical care to patients. The crises were characterized by high rates of medical errors, patient harm, and financial losses for both patients and healthcare providers.

Since the beginning of the current century, France, Germany, and Italy have passed statutes that aim to reform medical liability rules. These reforms were driven by a variety of factors, including the need to address the medical malpractice crises, improve patient safety, and ensure fair compensation for those who have been harmed by medical negligence.

The first chapter of this book explores the idea of medical malpractice crisis and its relationship with the insurance market. It also considers the reflections of American scholars on the issue. The chapter reconstructs the French, German, and Italian legal frameworks, as well as their insurance and litigation contexts, reviewing and commenting on the quantitative evidence that was collected before the reforms.

The second chapter briefly summarizes the debate on Medical Malpractice reforms in France, Germany, and Italy. It then analyzes the statutes that have been passed, distinguishing between reforms that consolidate case law and reforms that introduce innovative solutions, sometimes repealing court-developed doctrines. In particular, the chapter examines in a comparative perspective the different options adopted in these Civil Law countries with regard to the rules on liability, burden of proof, statute of limitations, and damages.

The third chapter reviews and analyzes the current available data related to medical malpractice litigation. It examines the types of medical malpractice cases that are filed, the outcomes of these cases, and the factors that influence the success or failure of medical malpractice litigation. The chapter also discusses the challenges that healthcare professionals face in defending themselves against medical malpractice claims.



Chapter 1: Medical Malpractice Crisis and its Relationship with the Insurance Market:

In the United States, the medical malpractice crisis was primarily driven by the high rates of medical errors and patient harm. The insurance market was also significantly impacted by the medical malpractice crisis, as healthcare providers faced increased premiums. premiums and increased risk of litigation.

The first chapter explores the idea of medical malpractice crisis and its relationship with the insurance market. It begins by defining the concept of medical malpractice crisis and its historical context. The chapter then discusses the relationship between medical malpractice crisis and the insurance market, including the impact of medical malpractice claims on insurance premiums and the development of insurance markets for medical malpractice.

The chapter also considers the reflections of American scholars on the issue of medical malpractice crisis and its relationship with the insurance market. American scholars have argued that the medical malpractice crisis is primarily driven by the high rates of medical errors and that the insurance market is a significant factor in this crisis. They have also argued that the insurance market is inefficient and that it fails to provide adequate protection for healthcare professionals.

The chapter reconstructs the French, German, and Italian legal frameworks, as well as their insurance and litigation contexts, reviewing and commenting on the quantitative evidence that was collected before the reforms. The evidence includes data on the number of medical malpractice claims filed, the outcomes of these claims, and the factors that influence the success or failure of medical malpractice litigation.

The chapter also discusses the impact of the reforms on the insurance market. The reforms have led to a reduction in the number of medical malpractice claims filed and a decrease in the premiums paid by healthcare providers. The reforms have also led to the development of new insurance markets for medical malpractice, which provide coverage for healthcare professionals who are sued for medical malpractice.

The chapter concludes by discussing the implications of the findings for the regulation of medical malpractice in other countries. The findings suggest that the regulation of medical malpractice should be based on a comprehensive understanding of the relationship between medical malpractice crisis and the insurance market. The findings also suggest that the regulation of medical malpractice should be tailored to the specific legal and insurance contexts of each country.



Chapter 2: Debate on Medical Malpractice Reforms in France, Germany, and Italy:

In France, Germany, and Italy, the debate on Medical Malpractice reforms has been ongoing for several decades. The reforms have been driven by a variety of factors, including the need to address the medical malpractice crises, improve patient safety, and ensure fair compensation for those who have been harmed by medical negligence.

The second chapter briefly summarizes the debate on Medical Malpractice reforms in France, Germany, and Italy. It begins by discussing the historical context of the debate on Medical Malpractice reforms in these countries. The chapter then discusses the main arguments for and against Medical Malpractice reforms.

The main arguments for Medical Malpractice reforms include the need to address the medical malpractice crises, improve patient safety, and ensure fair compensation for those who have been harmed by medical negligence. The main arguments against Medical Malpractice reforms include the concern that the reforms may lead to a reduction in the quality of medical care and the increase in healthcare costs.

The chapter analyzes the statutes that have been passed in France, Germany, and Italy, distinguishing between reforms that consolidate case law and reforms that introduce innovative solutions. The reforms that consolidate case law include the introduction of new rules on liability, burden of proof, and statute of limitations. The reforms that introduce innovative solutions include the introduction of new rules on damages and the introduction of new mechanisms for dispute resolution.

The chapter also examines the different options adopted in these Civil Law countries with regard to the rules on liability, burden of proof, statute of limitations, and damages. The options include the introduction of a no-fault system, the introduction of a pure contributory negligence system, and the introduction of a mixed system. The chapter also examines the different options adopted in these Civil Law countries with regard to the rules on damages, including the introduction of caps on damages and the introduction of punitive damages.

The chapter also examines the reforms of insurance, procedural, and evidence law, to the extent they affect medical malpractice cases. The reforms of insurance law include the introduction of new rules on coverage and exclusions. The reforms of procedural law include the introduction of new rules on discovery and evidence. The reforms of evidence law include the introduction of new rules on expert testimony and the introduction of new rules on the admissibility of evidence.

The chapter concludes by discussing the implications of the findings for the regulation of medical malpractice in other countries. The findings suggest that the regulation of medical malpractice should be based on a comprehensive understanding of the relationship between medical malpractice crisis and the insurance market. The findings also suggest that the regulation of medical malpractice should be tailored to the specific legal and insurance contexts of each country.



Chapter 3: Current Available Data Related to Medical Malpractice Litigation:

In recent years, there has been a significant increase in the amount of data available related to medical malpractice litigation. This data provides valuable insights into the types of medical malpractice cases that are filed, the outcomes of these cases, and the factors that influence the success or failure of medical malpractice litigation.

The third chapter reviews and analyzes the current available data related to medical malpractice litigation. It begins by discussing the types of medical malpractice cases that are filed. The types of medical malpractice cases include medical errors, negligence, and malpractice. The chapter then discusses the outcomes of these cases. The outcomes of these cases include settlements, verdicts, and appeals.

The chapter also discusses the factors that influence the success or failure of medical malpractice litigation. The factors that influence the success or failure of medical malpractice litigation include the strength of the evidence, the skill of the attorney, the conduct of the healthcare provider, and the legal and insurance contexts of the case.

The chapter also discusses the challenges that healthcare professionals face in defending themselves against medical malpractice claims. The challenges include the difficulty of proving liability, the high cost of litigation, and the emotional toll that medical malpractice litigation can take on healthcare professionals.

The chapter concludes by discussing the implications of the findings for the regulation of medical malpractice in other countries. The findings suggest that the regulation of medical malpractice should be based on a comprehensive understanding of the relationship between medical malpractice crisis and the insurance market. The findings also suggest that the regulation of medical malpractice should be tailored to the specific legal and insurance contexts of each country.

In conclusion, this book aims to analyze the legal tools that the legislatures of France, Germany, and Italy adopted in order to regulate medical malpractice. The first chapter explores the idea of medical malpractice crisis and its relationship with the insurance market, also considering the reflections of American scholars. The second chapter briefly summarizes the debate on Medical Malpractice reforms in France, Germany, and Italy. The third chapter reviews and analyzes the current available data related to medical malpractice litigation. The findings suggest that the regulation of medical malpractice should be based on a comprehensive understanding of the relationship between medical malpractice crisis and the insurance market. The findings also suggest that the regulation of medical malpractice should be tailored to the specific legal and insurance contexts of each country.


Dimension: 216 x 138 (mm)
ISBN-13: 9781032576282

UK and International shipping information

UK Delivery and returns information:

  • Delivery within 2 - 3 days when ordering in the UK.
  • Shipping fee for UK customers from £2.39. Fully tracked shipping service available.
  • Returns policy: Return within 30 days of receipt for full refund.

International deliveries:

Shulph Ink now ships to Australia, Belgium, Canada, France, Germany, Ireland, Italy, India, Luxembourg Saudi Arabia, Singapore, Spain, Netherlands, New Zealand, United Arab Emirates, United States of America.

  • Delivery times: within 5 - 10 days for international orders.
  • Shipping fee: charges vary for overseas orders. Only tracked services are available for most international orders. Some countries have untracked shipping options.
  • Customs charges: If ordering to addresses outside the United Kingdom, you may or may not incur additional customs and duties fees during local delivery.
View full details